EIF2AK3 mutations in South Indian children with permanent neonatal diabetes mellitus associated with Wolcott-Rallison syndrome

Pediatric Diabetes

Volumn 15, Issue 4, 2014, Pages 313-318

  Jahnavi, Suresh ^a   Poovazhagi, Varadarajan ^b   Kanthimathi, Sekar ^a   Gayathri, Vijay ^a   Mohan, Viswanathan ^a,c   Radha, Venkatesan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR CHILDREN   (India)

^c Dr Mohan's Diabetes Specialities Centre   (India)

Author keywords

EIF2AK3; PERK; PNDM; WRS

Indexed keywords

EUKARYOTIC INITIATION FACTOR 2 ALPHA K3; INITIATION FACTOR; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SHORT ACTING INSULIN; THYROTROPIN; UNCLASSIFIED DRUG; EIF2AK3 PROTEIN, HUMAN; PROTEIN KINASE R;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOSOMAL RECESSIVE DISORDER; BIRTH WEIGHT; BONE DYSPLASIA; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONSANGUINEOUS MARRIAGE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EIF2AK3 GENE; EXON; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; GROWTH RETARDATION; HUMAN; HYPERGLYCEMIA; HYPOTHYROIDISM; INFANT; LIVER DISEASE; MALE; MYCOSIS; NEWBORN DIABETES MELLITUS; ONSET AGE; OSTEOPENIA; PERMANENT NEONATAL DIABETES MELLITUS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THYROID DISEASE; TONIC CLONIC SEIZURE; UREMIA; WOLCOTT RALLISON SYNDROME; AMINO ACID SUBSTITUTION; CHONDRODYSPLASIA; CONGENITAL HYPOTHYROIDISM; CONSANGUINITY; EPIPHYSIS; FOLLOW UP; GENETIC ASSOCIATION; GENETICS; HEPATIC INSUFFICIENCY; HOMOZYGOTE; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; MUTATION; NEWBORN; PATHOPHYSIOLOGY; PEDIGREE; POINT MUTATION; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX;

AMINO ACID SUBSTITUTION; CONGENITAL HYPOTHYROIDISM; CONSANGUINITY; DIABETES MELLITUS, TYPE 1; EIF-2 KINASE; EPIPHYSES; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HEPATIC INSUFFICIENCY; HOMOZYGOTE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MUTATION; OSTEOCHONDRODYSPLASIAS; PEDIGREE; POINT MUTATION; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX;

EID: 84901595947     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12089     Document Type: Article

References (18)

1. Dele'pine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000: 25: 406-409.
2. Wolcott CD, Rallison ML. Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972: 80: 292-297.
3. Bin-Abbas B, Shabib S, Hainu B, Al-Ashwal A. Wolcott-Rallison syndrome. Clinical, radiological and histological finding in a Saudi child. Ann Saudi Med 2001: 21 (1-2): 73-74.
4. Rubio-Cabezas O, Patch AM, Minton JA et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 2009 Nov: 94: 4162-4170.
5. Biason-Lauber A, Lang-Muritano M, Vaccaro T, Schoenle EJ. Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene. Diabetes 2002 Jul: 51: 2301-2305.
6. Deepa M, Pradeepa R, Rema M et al. The Chennai Urban Rural Epidemiology Study (CURES)-Study design and methodology (Urban Component) (CURES 1). J Assoc Physicians India 2003: 51: 863-870.
7. Rema M, Mohan V, Deepa R, Ravikumar A. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004: 27: 1962-1967.
8. Ellard S, Flanagan SE, Girard CA et al. Permanent neonatal diabetes caused by dominant, recessive or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet 2007 Aug: 81: 375-382.
9. Stoy J, Steiner DF, Park Y, Ye H, Philipson LH, Bell GI. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Metab Dis 2012: 13: 79-81.
10. Boutin P, Vasseur F, Samson C, Wahl C. Froguel P (2001) Routine mutation screening of HNF-1alpha and GCK genes in MODY diagnosis: how effective are the techniques of DHPLC and direct sequencing used in combination? Diabetologia 2001: 44: 775-778.
11. Brickwood S, Bonthron DT, Al-Gazali LI et al. Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet 2003: 40: 685-689.
12. Jahnavi S, Poovazhagi V, Mohan V et al. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children. Clin Genet 2013: 83: 439-445.
13. Zhang W, Feng D, Li Y, Lida K, McGrath B, Cavener DR. PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for post natal glucose homeostasis. Cell Metab 2006: 4: 491-497.
14. Lida K, Li Y, McGrath B, Frank A, Cavener DR. PERK eif2 alpha kinase is required to regulate the viability of the exocrine pancreas in mice. BMC Cell Biol 2007: 8: 38.
15. Bin-Abbas B, Al-Mulhim A, Al-Ashwal A. Wolcott-Rallison syndrome in two siblings with isolated central hypothyroidism. Am J Med Genet 2002: 111: 187-190.
16. Senée V, Vattem KM, Delépine M et al. Wolcott-Rallison syndrome, clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004: 53: 1876-1883.
17. Ozbek MN, Senee V, Aydemir S et al. Wolcott-Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature. Pediatr Diabetes 2010: 11: 279-285.
18. Iyer S, Korada M, Rainbow L et al. Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr 2004: 93: 1195-1201.